Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Regulatory News:
Vitrolife (STO:VITR):
Second quarter:
Continuing operations
•Sales growth was 29 percent in local currency. Sales amounted to SEK 116 (95) million, corresponding to an increase of 22 percent in SEK.
•Operating income (EBIT) amounted to SEK 19 (13) million, corresponding to an operating margin of 16 (13) percent.
Help employers find you! Check out all the jobs and post your resume.
